scholarly journals Association between obstructive sleep apnea and thyroid cancer incidence: a national health insurance data study

2021 ◽  
Author(s):  
Shih-Wei Lai ◽  
Yu-Hung Kuo ◽  
Kuan-Fu Liao
Keyword(s):  
Obstructive Sleep Apnea ◽  
Thyroid Cancer ◽  
Health Insurance ◽  
Sleep Apnea ◽  
National Health Insurance ◽  
Cancer Incidence ◽  
Health Insurance Data ◽  
Obstructive Sleep ◽  
Insurance Data ◽  
Thyroid Cancer Incidence

scholarly journals The impact of national health insurance on the compliance of positive airway pressure therapy in patients with obstructive sleep apnea

2021 ◽  
Author(s):  
Woori Choi ◽  
Mirye Bae ◽  
YOOSAM CHUNG
Keyword(s):  
Obstructive Sleep Apnea ◽  
Health Insurance ◽  
Sleep Apnea ◽  
National Health Insurance ◽  
National Health ◽  
Airway Pressure ◽  
Positive Airway Pressure ◽  
Pressure Therapy ◽  
Obstructive Sleep ◽  
The Impact

Objectives Compliance with positive airway pressure (PAP) in patients with obstructive sleep apnea (OSA) directly affects its treatment efficacy. Since July 2018, polysomnography and PAP therapy have been covered by the national health insurance (NHI), which has reduced the price barrier and promoted PAP therapy in Korea. This study aimed to compare changes in PAP compliance before and after NHI implementation.MethodsThis study is a retrospective analysis in a tertiary hospital setting in Korea. From 2011 to 2019, patients with OSA (apnea-hypopnea index

scholarly journals The incidence of malignant brain tumors is increased in patients with obstructive sleep apnea: A national health insurance survey

PLoS ONE ◽  
2020 ◽  
Vol 15 (11) ◽  
pp. e0241598
Author(s):  
Jae Hoon Cho ◽  
Young Chang Lim ◽  
Kyung-Do Han ◽  
Jae Yong Lee ◽  
Ji Ho Choi
Keyword(s):  
Obstructive Sleep Apnea ◽  
Brain Tumor ◽  
Health Insurance ◽  
Sleep Apnea ◽  
Brain Tumors ◽  
National Health Insurance ◽  
National Health ◽  
Newly Diagnosed ◽  
Malignant Brain Tumors ◽  
Obstructive Sleep

The association between obstructive sleep apnea (OSA) and malignant brain tumors has yet to be fully investigated. Therefore, the purpose of this study was to elucidate the effect of OSA on brain tumor incidence based on the Korea National Health Insurance Service (KNHIS) dataset. The KNHIS data between 2007 and 2014 were analyzed, and the primary endpoint was newly diagnosed malignant brain tumor. A total of 198,574 subjects aged ≥ 20 years with newly diagnosed OSA were enrolled in the study, and 992,870 individuals were selected as a control group based on propensity score matching (PSM) by gender and age. The average follow-up duration was 4.8 ± 2.3 years. The hazard ratios (HRs) for brain tumor for patients with OSA were 1.78 (95% confidence interval [CI]: 1.42–2.21) in Model 1 (not adjusted with any covariate) and 1.67 (95% CI: 1.34–2.09) in Model 2 (adjusted for income level, diabetes, hypertension, dyslipidemia, and COPD). In subgroup analysis by gender, the odds ratios (OR) of OSA were 1.82 (95% CI: 1.41–2.33) in men and 1.26 (95% CI: 0.74–2.03) in women. The ORs were 1.97 (95% CI: 1.15–3.24) in the older (age ≥ 65 years) group, 1.66 (95% CI: 1.25–2.17) in the middle-aged (40 ≤ age < 65 years) group, and 1.41 (0.78–2.44) in the young (20 ≤ age < 40 years) group. In conclusion, OSA may increase the incidence of brain tumors.

Sign in / Sign up

Export Citation Format

Share Document